Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)

Introduction Idiopathic nephrotic syndrome is the most common glomerular disease in childhood with an incidence of 1.8 cases per 100 000 children in Germany. The treatment of the first episode implies two aspects: induction of remission and sustainment of remission. The recent Kidney Disease Improvi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ehren, Rasmus (VerfasserIn) , Fichtner, Alexander (VerfasserIn) , Höcker, Britta (VerfasserIn) , Kästner, Bärbel (VerfasserIn) , Luntz, Steffen P. (VerfasserIn) , Sander, Anja (VerfasserIn) , Tönshoff, Burkhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 Feb 2018
In: BMJ open
Year: 2018, Jahrgang: 8, Heft: 10, Pages: 1-10
ISSN:2044-6055
DOI:10.1136/bmjopen-2018-024882
Online-Zugang:Verlag, Volltext: https://doi.org/10.1136/bmjopen-2018-024882
Verlag, Volltext: https://bmjopen.bmj.com/content/8/10/e024882
Volltext
Verfasserangaben:Rasmus Ehren, Marcus R. Benz, Jorg Doetsch, Alexander Fichtner, Jutta Gellermann, Dieter Haffner, Britta Höcker, Peter F. Hoyer, Bärbel Kästner, Markus J. Kemper, Martin Konrad, Steffen Luntz, Uwe Querfeld, Anja Sander, Burkhard Toenshoff, Lutz T. Weber

MARC

LEADER 00000caa a2200000 c 4500
001 1670165930
003 DE-627
005 20230427055705.0
007 cr uuu---uuuuu
008 190729s2018 xx |||||o 00| ||eng c
024 7 |a 10.1136/bmjopen-2018-024882  |2 doi 
035 |a (DE-627)1670165930 
035 |a (DE-599)KXP1670165930 
035 |a (OCoLC)1341234802 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ehren, Rasmus  |e VerfasserIn  |0 (DE-588)1188739964  |0 (DE-627)166764971X  |4 aut 
245 1 0 |a Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone  |b protocol for a randomised, controlled, multicentre trial (INTENT study)  |c Rasmus Ehren, Marcus R. Benz, Jorg Doetsch, Alexander Fichtner, Jutta Gellermann, Dieter Haffner, Britta Höcker, Peter F. Hoyer, Bärbel Kästner, Markus J. Kemper, Martin Konrad, Steffen Luntz, Uwe Querfeld, Anja Sander, Burkhard Toenshoff, Lutz T. Weber 
264 1 |c 1 Feb 2018 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.07.2019 
520 |a Introduction Idiopathic nephrotic syndrome is the most common glomerular disease in childhood with an incidence of 1.8 cases per 100 000 children in Germany. The treatment of the first episode implies two aspects: induction of remission and sustainment of remission. The recent Kidney Disease Improving Global Outcomes, American Academy of Pediatrics and German guidelines for the initial treatment of the first episode of a nephrotic syndrome recommend a 12-week course of prednisone. Despite being effective, this treatment is associated with pronounced glucocorticoid-associated toxicity due to high-dose prednisone administration over a prolonged period of time. The aim of the INTENT study (Initial treatment of steroid-sensitive idiopathic nephrotic syndrom in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial) is to show that an alternative treatment regimen with mycophenolic acid is not inferior regarding sustainment of remission, but with lower toxicity compared with treatment with glucocorticoids only. - Methods and design The study is designed as an open, randomised, controlled, multicentre trial. 340 children with a first episode of steroid-sensitive nephrotic syndrome and who achieved remission by a standard prednisone regimen will be enrolled in the trial and randomised to one of two treatment arms. The standard care group will be treated with prednisone for a total of 12 weeks; in the experimental group the treatment is switched to mycophenolate mofetil, also for a total of 12 weeks in treatment duration. The primary endpoint is the occurrence of a treated relapse within 24 months after completion of initial treatment. - Ethics and dissemination Ethics approval for this trial was granted by the ethics committee of the Medical Faculty of the University of Heidelberg (AFmu-554/2014). The study results will be published in accordance with the Consolidated Standards of Reporting Trials statement and the Standard Protocol Items: Recommendations for Interventional Trials guidelines. Our findings will be submitted to major international paediatric nephrology and general paediatric conferences and submitted for publication in a peer-reviewed, open-access journal. - Trial registration number DRKS0006547; EudraCT2014-001991-76; Pre-result. - Date of registration 30 October 2014; 24 February 2017. 
650 4 |a alternative treatment 
650 4 |a mycophenolate mofetil 
650 4 |a steroid-sensitive nephrotic syndrome 
650 4 |a steroids 
700 1 |a Fichtner, Alexander  |e VerfasserIn  |0 (DE-588)1070019860  |0 (DE-627)823188094  |0 (DE-576)429697740  |4 aut 
700 1 |a Höcker, Britta  |d 1974-  |e VerfasserIn  |0 (DE-588)122785673  |0 (DE-627)706042816  |0 (DE-576)293419795  |4 aut 
700 1 |a Kästner, Bärbel  |d 1969-  |e VerfasserIn  |0 (DE-588)120087855  |0 (DE-627)696368390  |0 (DE-576)29203475X  |4 aut 
700 1 |a Luntz, Steffen P.  |d 1968-  |e VerfasserIn  |0 (DE-588)120890216  |0 (DE-627)70506624X  |0 (DE-576)292433077  |4 aut 
700 1 |a Sander, Anja  |d 1986-  |e VerfasserIn  |0 (DE-588)1071418173  |0 (DE-627)825832217  |0 (DE-576)433071567  |4 aut 
700 1 |a Tönshoff, Burkhard  |e VerfasserIn  |0 (DE-588)1032445823  |0 (DE-627)738463493  |0 (DE-576)173494196  |4 aut 
773 0 8 |i Enthalten in  |t BMJ open  |d London : BMJ Publishing Group, 2011  |g 8(2018,10) Artikel-Nummer e024882, 10 Seiten  |h Online-Ressource  |w (DE-627)654747075  |w (DE-600)2599832-8  |w (DE-576)339269340  |x 2044-6055  |7 nnas  |a Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone protocol for a randomised, controlled, multicentre trial (INTENT study) 
773 1 8 |g volume:8  |g year:2018  |g number:10  |g pages:1-10  |g extent:10  |a Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone protocol for a randomised, controlled, multicentre trial (INTENT study) 
856 4 0 |u https://doi.org/10.1136/bmjopen-2018-024882  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://bmjopen.bmj.com/content/8/10/e024882  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190729 
993 |a Article 
994 |a 2018 
998 |g 1032445823  |a Tönshoff, Burkhard  |m 1032445823:Tönshoff, Burkhard  |d 910000  |d 910500  |e 910000PT1032445823  |e 910500PT1032445823  |k 0/910000/  |k 1/910000/910500/  |p 15 
998 |g 1071418173  |a Sander, Anja  |m 1071418173:Sander, Anja  |d 910000  |d 999701  |e 910000PS1071418173  |e 999701PS1071418173  |k 0/910000/  |k 1/910000/999701/  |p 14 
998 |g 120890216  |a Luntz, Steffen P.  |m 120890216:Luntz, Steffen P.  |d 910000  |d 913000  |e 910000PL120890216  |e 913000PL120890216  |k 0/910000/  |k 1/910000/913000/  |p 12 
998 |g 120087855  |a Kästner, Bärbel  |m 120087855:Kästner, Bärbel  |d 910000  |d 913000  |e 910000PK120087855  |e 913000PK120087855  |k 0/910000/  |k 1/910000/913000/  |p 9 
998 |g 122785673  |a Höcker, Britta  |m 122785673:Höcker, Britta  |d 910000  |d 910500  |e 910000PH122785673  |e 910500PH122785673  |k 0/910000/  |k 1/910000/910500/  |p 7 
998 |g 1070019860  |a Fichtner, Alexander  |m 1070019860:Fichtner, Alexander  |d 910000  |d 910500  |e 910000PF1070019860  |e 910500PF1070019860  |k 0/910000/  |k 1/910000/910500/  |p 4 
999 |a KXP-PPN1670165930  |e 3499604094 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.1136/bmjopen-2018-024882"],"eki":["1670165930"]},"title":[{"subtitle":"protocol for a randomised, controlled, multicentre trial (INTENT study)","title":"Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone","title_sort":"Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"1 Feb 2018","dateIssuedKey":"2018"}],"relHost":[{"recId":"654747075","origin":[{"dateIssuedKey":"2011","publisherPlace":"London","publisher":"BMJ Publishing Group","dateIssuedDisp":"2011-"}],"title":[{"title_sort":"BMJ open","title":"BMJ open"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2599832-8"],"eki":["654747075"],"issn":["2044-6055"]},"note":["Gesehen am 02.10.20"],"pubHistory":["2011 -"],"language":["eng"],"part":{"volume":"8","year":"2018","text":"8(2018,10) Artikel-Nummer e024882, 10 Seiten","issue":"10","extent":"10","pages":"1-10"},"disp":"Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone protocol for a randomised, controlled, multicentre trial (INTENT study)BMJ open","type":{"bibl":"periodical","media":"Online-Ressource"}}],"language":["eng"],"name":{"displayForm":["Rasmus Ehren, Marcus R. Benz, Jorg Doetsch, Alexander Fichtner, Jutta Gellermann, Dieter Haffner, Britta Höcker, Peter F. Hoyer, Bärbel Kästner, Markus J. Kemper, Martin Konrad, Steffen Luntz, Uwe Querfeld, Anja Sander, Burkhard Toenshoff, Lutz T. Weber"]},"note":["Gesehen am 29.07.2019"],"person":[{"display":"Ehren, Rasmus","given":"Rasmus","role":"aut","family":"Ehren"},{"given":"Alexander","display":"Fichtner, Alexander","role":"aut","family":"Fichtner"},{"role":"aut","family":"Höcker","given":"Britta","display":"Höcker, Britta"},{"role":"aut","family":"Kästner","display":"Kästner, Bärbel","given":"Bärbel"},{"given":"Steffen P.","display":"Luntz, Steffen P.","family":"Luntz","role":"aut"},{"display":"Sander, Anja","given":"Anja","family":"Sander","role":"aut"},{"given":"Burkhard","display":"Tönshoff, Burkhard","role":"aut","family":"Tönshoff"}],"recId":"1670165930"} 
SRT |a EHRENRASMUINITIALTRE1201